BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19187720)

  • 1. Blood cytokines and BPD.
    Jobe AH
    J Pediatr; 2009 Jan; 154(1):A2. PubMed ID: 19187720
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
    Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
    J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants.
    Shima Y; Nishimaki S; Nakajima M; Kumasaka S; Migita M
    J Perinatol; 2011 May; 31(5):330-4. PubMed ID: 21127468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
    Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
    Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates.
    Mittendorf R; Covert R; Montag AG; elMasri W; Muraskas J; Lee KS; Pryde PG
    J Perinat Med; 2005; 33(5):428-34. PubMed ID: 16238538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.
    Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M
    J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines and bronchopulmonary dysplasia].
    Burón Martínez E; Blanco Quirós A; Garrote JA; Oyagüez P; Fernández Calvo JL
    An Esp Pediatr; 1998 Aug; 49(2):116-9. PubMed ID: 9773543
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro-inflammatory immune responses in leukocytes of premature infants exposed to maternal chorioamnionitis or funisitis.
    Jackson CM; Wells CB; Tabangin ME; Meinzen-Derr J; Jobe AH; Chougnet CA
    Pediatr Res; 2017 Feb; 81(2):384-390. PubMed ID: 27814345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia.
    Speer CP
    Neonatology; 2009; 95(4):353-61. PubMed ID: 19494557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe BPD is decreasing.
    Jobe AH
    J Pediatr; 2005 Apr; 146(4):A2. PubMed ID: 15812438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Health status at the age of 5-7 years of preterm infants with and without bronchopulmonary dysplasia].
    Kwinta P; Tomasik T; Klimek M; Cichocka-Jarosz E; Lis G; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):21-6. PubMed ID: 19485251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants.
    Janér J; Andersson S; Kajantie E; Lassus P
    Pediatrics; 2009 Apr; 123(4):1142-6. PubMed ID: 19336373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
    Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of pulse oximetry with bronchopulmonary dysplasia.
    Eggert LD
    J Perinatol; 1987; 7(4):336. PubMed ID: 3505272
    [No Abstract]   [Full Text] [Related]  

  • 17. Questioning role of hypochloremia in bronchopulmonary dysplasia.
    Pediatrics; 1986 Dec; 78(6):1172-3. PubMed ID: 3786051
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia.
    May C; Williams O; Milner AD; Peacock J; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F205-9. PubMed ID: 19383857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal Vascular Origins of Bronchopulmonary Dysplasia.
    Mandell EW; Abman SH
    J Pediatr; 2017 Jun; 185():7-10.e1. PubMed ID: 28359535
    [No Abstract]   [Full Text] [Related]  

  • 20. Does short-term ventilation for semielective surgery influence the course of bronchopulmonary dysplasia in preterms?
    Fischer D; Weiss K; Buxmann H; Bremerich DH; Schloesser RL
    Klin Padiatr; 2009 Sep; 221(5):310-1. PubMed ID: 19707995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.